<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ard.bmj.com/">
<title>Ann. Rheum. Dis.: Most-Read Full-Text Articles</title>
<link>http://ard.bmj.com/</link>
<description>Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2012-05-03</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/69/9/1580?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/69/6/964?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/67/2/195?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/71/5/642?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/annrheumdis-2011-200954v1?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/71/1/4?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/annrheumdis-2011-200937v5?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/71/4/484?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/71/5/638?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://ard.bmj.com/cgi/content/short/70/6/1003?rss=1&#x26;amp;ssource=mfr" />
 </rdf:Seq>
</items>
</channel>
<item rdf:about="http://ard.bmj.com/cgi/content/short/69/9/1580?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative]]></title>
<link>http://ard.bmj.com/cgi/content/short/69/9/1580?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Daniel Aletaha, Tuhina Neogi, Alan J Silman, Julia Funovits, David T Felson, Clifton O Bingham III, Neal S Birnbaum, Gerd R Burmester, Vivian P Bykerk, Marc D Cohen, Bernard Combe, Karen H Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna MW Hazes, Kathryn Hobbs, Tom WJ Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K Kvien, Timothy Laing, Philip Mease, Henri A Menard, Larry W Moreland, Raymond L Naden, Theodore Pincus, Josef S Smolen, Ewa Stanislawska-Biernat, Deborah Symmons, Paul P Tak, Katherine S Upchurch, Jiri Vencovsky, Frederick Wolfe, Gillian Hawker<br />Sep  1, 2010; 69:1580-1588<br />Criteria]]></description>
<dc:creator>Daniel Aletaha, Tuhina Neogi, Alan J Silman, Julia Funovits, David T Felson, Clifton O Bingham III, Neal S Birnbaum, Gerd R Burmester, Vivian P Bykerk, Marc D Cohen, Bernard Combe, Karen H Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna MW Hazes, Kathryn Hobbs, Tom WJ Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K Kvien, Timothy Laing, Philip Mease, Henri A Menard, Larry W Moreland, Raymond L Naden, Theodore Pincus, Josef S Smolen, Ewa Stanislawska-Biernat, Deborah Symmons, Paul P Tak, Katherine S Upchurch, Jiri Vencovsky, Frederick Wolfe, Gillian Hawker</dc:creator>
<dc:date>2010-09-01</dc:date>
<dc:identifier>10.1136/ard.2010.138461</dc:identifier>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative]]></dc:title>
<prism:number>9</prism:number>
<prism:volume>69</prism:volume>
<prism:endingPage>1588</prism:endingPage>
<prism:publicationDate>2010-09-01</prism:publicationDate>
<prism:section>Criteria</prism:section>
<prism:startingPage>1580</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/69/6/964?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs]]></title>
<link>http://ard.bmj.com/cgi/content/short/69/6/964?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Josef S Smolen, Robert Landewe, Ferdinand C Breedveld, Maxime Dougados, Paul Emery, Cecile Gaujoux-Viala, Simone Gorter, Rachel Knevel, Jackie Nam, Monika Schoels, Daniel Aletaha, Maya Buch, Laure Gossec, Tom Huizinga, Johannes W J W Bijlsma, Gerd Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan Gomez-Reino, Marios Kouloumas, Tore K Kvien, Emilio Martin-Mola, Iain McInnes, Karel Pavelka, Piet van Riel, Marieke Scholte, David L Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin L Winthrop, John Wong, Angela Zink, Desiree van der Heijde<br />Jun  1, 2010; 69:964-975<br />Recommendations]]></description>
<dc:creator>Josef S Smolen, Robert Landewe, Ferdinand C Breedveld, Maxime Dougados, Paul Emery, Cecile Gaujoux-Viala, Simone Gorter, Rachel Knevel, Jackie Nam, Monika Schoels, Daniel Aletaha, Maya Buch, Laure Gossec, Tom Huizinga, Johannes W J W Bijlsma, Gerd Burmester, Bernard Combe, Maurizio Cutolo, Cem Gabay, Juan Gomez-Reino, Marios Kouloumas, Tore K Kvien, Emilio Martin-Mola, Iain McInnes, Karel Pavelka, Piet van Riel, Marieke Scholte, David L Scott, Tuulikki Sokka, Guido Valesini, Ronald van Vollenhoven, Kevin L Winthrop, John Wong, Angela Zink, Desiree van der Heijde</dc:creator>
<dc:date>2010-06-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs]]></dc:title>
<prism:number>6</prism:number>
<prism:volume>69</prism:volume>
<prism:endingPage>975</prism:endingPage>
<prism:publicationDate>2010-06-01</prism:publicationDate>
<prism:section>Recommendations</prism:section>
<prism:startingPage>964</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/67/2/195?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics]]></title>
<link>http://ard.bmj.com/cgi/content/short/67/2/195?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, D Isenberg, C G M Kallenberg, M Khamashta, J C Piette, M Schneider, J Smolen, G Sturfelt, A Tincani, R van Vollenhoven, C Gordon, D T Boumpas<br />Feb  1, 2008; 67:195-205<br />Extended reports]]></description>
<dc:creator>G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I M Gilboe, F Houssiau, T Huizinga, D Isenberg, C G M Kallenberg, M Khamashta, J C Piette, M Schneider, J Smolen, G Sturfelt, A Tincani, R van Vollenhoven, C Gordon, D T Boumpas</dc:creator>
<dc:date>2008-02-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>67</prism:volume>
<prism:endingPage>205</prism:endingPage>
<prism:publicationDate>2008-02-01</prism:publicationDate>
<prism:section>Extended reports</prism:section>
<prism:startingPage>195</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/71/5/642?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study]]></title>
<link>http://ard.bmj.com/cgi/content/short/71/5/642?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[S Clockaerts, G J V M Van Osch, Y M Bastiaansen-Jenniskens, J A N Verhaar, F Van Glabbeek, J B Van Meurs, H J M Kerkhof, A Hofman, B H Ch Stricker, S M Bierma-Zeinstra<br />May  1, 2012; 71:642-647<br />Clinical and epidemiological research]]></description>
<dc:creator>S Clockaerts, G J V M Van Osch, Y M Bastiaansen-Jenniskens, J A N Verhaar, F Van Glabbeek, J B Van Meurs, H J M Kerkhof, A Hofman, B H Ch Stricker, S M Bierma-Zeinstra</dc:creator>
<dc:date>2012-05-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study]]></dc:title>
<prism:number>5</prism:number>
<prism:volume>71</prism:volume>
<prism:endingPage>647</prism:endingPage>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section>Clinical and epidemiological research</prism:section>
<prism:startingPage>642</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/annrheumdis-2011-200954v1?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[The risks of smoking in patients with spondyloarthritides]]></title>
<link>http://ard.bmj.com/cgi/content/short/annrheumdis-2011-200954v1?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Jurgen Braun, Joachim Sieper, Angela Zink<br />Feb 13, 2012; 0:201120095-201120095<br />Editorials]]></description>
<dc:creator>Jurgen Braun, Joachim Sieper, Angela Zink</dc:creator>
<dc:date>2012-02-13</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[The risks of smoking in patients with spondyloarthritides]]></dc:title>
<prism:number>2012</prism:number>
<prism:volume>0</prism:volume>
<prism:endingPage>201120095</prism:endingPage>
<prism:publicationDate>2012-02-13</prism:publicationDate>
<prism:section>Editorials</prism:section>
<prism:startingPage>201120095</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/71/1/4?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies]]></title>
<link>http://ard.bmj.com/cgi/content/short/71/1/4?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[L Gossec, J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde, O FitzGerald, D Aletaha, P Balint, D Boumpas, J Braun, F C Breedveld, G Burmester, J D Canete, M de Wit, H Dagfinrud, K de Vlam, M Dougados, P Helliwell, A Kavanaugh, T K Kvien, R Landewe, T Luger, M Maccarone, D McGonagle, N McHugh, I B McInnes, C Ritchlin, J Sieper, P P Tak, G Valesini, J Vencovsky, K L Winthrop, A Zink, P Emery<br />Jan  1, 2012; 71:4-12<br />Recommendations]]></description>
<dc:creator>L Gossec, J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde, O FitzGerald, D Aletaha, P Balint, D Boumpas, J Braun, F C Breedveld, G Burmester, J D Canete, M de Wit, H Dagfinrud, K de Vlam, M Dougados, P Helliwell, A Kavanaugh, T K Kvien, R Landewe, T Luger, M Maccarone, D McGonagle, N McHugh, I B McInnes, C Ritchlin, J Sieper, P P Tak, G Valesini, J Vencovsky, K L Winthrop, A Zink, P Emery</dc:creator>
<dc:date>2012-01-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies]]></dc:title>
<prism:number>1</prism:number>
<prism:volume>71</prism:volume>
<prism:endingPage>12</prism:endingPage>
<prism:publicationDate>2012-01-01</prism:publicationDate>
<prism:section>Recommendations</prism:section>
<prism:startingPage>4</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/annrheumdis-2011-200937v5?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response]]></title>
<link>http://ard.bmj.com/cgi/content/short/annrheumdis-2011-200937v5?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Ronald F van Vollenhoven, Michelle A Petri, Ricard Cervera, David A Roth, Beulah N Ji, Christi S Kleoudis, Z John Zhong, William Freimuth<br />Apr  5, 2012; 0:201120093-201120093<br />Clinical and epidemiological research]]></description>
<dc:creator>Ronald F van Vollenhoven, Michelle A Petri, Ricard Cervera, David A Roth, Beulah N Ji, Christi S Kleoudis, Z John Zhong, William Freimuth</dc:creator>
<dc:date>2012-04-05</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response]]></dc:title>
<prism:number>2012</prism:number>
<prism:volume>0</prism:volume>
<prism:endingPage>201120093</prism:endingPage>
<prism:publicationDate>2012-04-05</prism:publicationDate>
<prism:section>Clinical and epidemiological research</prism:section>
<prism:startingPage>201120093</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/71/4/484?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative]]></title>
<link>http://ard.bmj.com/cgi/content/short/71/4/484?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Bhaskar Dasgupta, Marco A Cimmino, Hilal Maradit-Kremers, Wolfgang A Schmidt, Michael Schirmer, Carlo Salvarani, Artur Bachta, Christian Dejaco, Christina Duftner, Hanne Slott Jensen, Pierre Duhaut, Gyula Poor, Novak Pal Kaposi, Peter Mandl, Peter V Balint, Zsuzsa Schmidt, Annamaria Iagnocco, Carlotta Nannini, Fabrizio Cantini, Pierluigi Macchioni, Nicolo Pipitone, Montserrat Del Amo, Georgina Espigol-Frigole, Maria C Cid, Victor M Martinez-Taboada, Elisabeth Nordborg, Haner Direskeneli, Sibel Zehra Aydin, Khalid Ahmed, Brian Hazleman, Barbara Silverman, Colin Pease, Richard J Wakefield, Raashid Luqmani, Andy Abril, Clement J Michet, Ralph Marcus, Neil J Gonter, Mehrdad Maz, Rickey E Carter, Cynthia S Crowson, Eric L Matteson<br />Apr  1, 2012; 71:484-492<br />Criteria]]></description>
<dc:creator>Bhaskar Dasgupta, Marco A Cimmino, Hilal Maradit-Kremers, Wolfgang A Schmidt, Michael Schirmer, Carlo Salvarani, Artur Bachta, Christian Dejaco, Christina Duftner, Hanne Slott Jensen, Pierre Duhaut, Gyula Poor, Novak Pal Kaposi, Peter Mandl, Peter V Balint, Zsuzsa Schmidt, Annamaria Iagnocco, Carlotta Nannini, Fabrizio Cantini, Pierluigi Macchioni, Nicolo Pipitone, Montserrat Del Amo, Georgina Espigol-Frigole, Maria C Cid, Victor M Martinez-Taboada, Elisabeth Nordborg, Haner Direskeneli, Sibel Zehra Aydin, Khalid Ahmed, Brian Hazleman, Barbara Silverman, Colin Pease, Richard J Wakefield, Raashid Luqmani, Andy Abril, Clement J Michet, Ralph Marcus, Neil J Gonter, Mehrdad Maz, Rickey E Carter, Cynthia S Crowson, Eric L Matteson</dc:creator>
<dc:date>2012-04-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>71</prism:volume>
<prism:endingPage>492</prism:endingPage>
<prism:publicationDate>2012-04-01</prism:publicationDate>
<prism:section>Criteria</prism:section>
<prism:startingPage>484</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/71/5/638?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis]]></title>
<link>http://ard.bmj.com/cgi/content/short/71/5/638?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Danielle M Gerlag, Karim Raza, Lisa G M van Baarsen, Elisabeth Brouwer, Christopher D Buckley, Gerd R Burmester, Cem Gabay, Anca I Catrina, Andrew P Cope, Francois Cornelis, Solbritt Rantapaa Dahlqvist, Paul Emery, Stephen Eyre, Axel Finckh, Steffen Gay, Johanna M Hazes, Annette van der Helm-van Mil, Tom W J Huizinga, Lars Klareskog, Tore K Kvien, Cathryn Lewis, Klaus P Machold, Johan Ronnelid, Dirkjan van Schaardenburg, Georg Schett, Josef S Smolen, Sue Thomas, Jane Worthington, Paul P Tak<br />May  1, 2012; 71:638-641<br />]]></description>
<dc:creator>Danielle M Gerlag, Karim Raza, Lisa G M van Baarsen, Elisabeth Brouwer, Christopher D Buckley, Gerd R Burmester, Cem Gabay, Anca I Catrina, Andrew P Cope, Francois Cornelis, Solbritt Rantapaa Dahlqvist, Paul Emery, Stephen Eyre, Axel Finckh, Steffen Gay, Johanna M Hazes, Annette van der Helm-van Mil, Tom W J Huizinga, Lars Klareskog, Tore K Kvien, Cathryn Lewis, Klaus P Machold, Johan Ronnelid, Dirkjan van Schaardenburg, Georg Schett, Josef S Smolen, Sue Thomas, Jane Worthington, Paul P Tak</dc:creator>
<dc:date>2012-05-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis]]></dc:title>
<prism:number>5</prism:number>
<prism:volume>71</prism:volume>
<prism:endingPage>641</prism:endingPage>
<prism:publicationDate>2012-05-01</prism:publicationDate>
<prism:section></prism:section>
<prism:startingPage>638</prism:startingPage>
</item>
<item rdf:about="http://ard.bmj.com/cgi/content/short/70/6/1003?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial]]></title>
<link>http://ard.bmj.com/cgi/content/short/70/6/1003?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Robert F Spiera, Jessica K Gordon, Jamie N Mersten, Cynthia M Magro, Mansi Mehta, Horatio F Wildman, Stacey Kloiber, Kyriakos A Kirou, Stephen Lyman, Mary K Crow<br />Jun  1, 2011; 70:1003-1009<br />Clinical and epidemiological research]]></description>
<dc:creator>Robert F Spiera, Jessica K Gordon, Jamie N Mersten, Cynthia M Magro, Mansi Mehta, Horatio F Wildman, Stacey Kloiber, Kyriakos A Kirou, Stephen Lyman, Mary K Crow</dc:creator>
<dc:date>2011-06-01</dc:date>
<dc:publisher>British Medical Journal Publishing Group</dc:publisher>
<dc:title><![CDATA[Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial]]></dc:title>
<prism:number>6</prism:number>
<prism:volume>70</prism:volume>
<prism:endingPage>1009</prism:endingPage>
<prism:publicationDate>2011-06-01</prism:publicationDate>
<prism:section>Clinical and epidemiological research</prism:section>
<prism:startingPage>1003</prism:startingPage>
</item>
</rdf:RDF>
